Research and Markets - Next Generation Sequencers Market Report 2017 - Key Vendors are Agilent Technologies, Fluidigm Corporation, Genomatix, Illumina, Oxford Gene Technology, Qiagen, RainDance & Roche Sequencing

News provided by

May 11, 2017, 16:00 ET

DUBLIN, May 11, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Next Generation Sequencers - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand. The Global market is additionally analyzed by the following End-Use Segments: Pharmaceutical/Biotech, Industrial, and Government/Academia. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 93 companies including many key and niche players such as:

Agilent Technologies Inc. (US)
Becton, Dickinson and Company (BD) (US)
Fluidigm Corporation (US)
Genomatix GmbH (Germany)
Illumina, Inc. (US)
Oxford Gene Technology (UK)
Oxford Nanopore Technologies (UK)
Pacific Biosciences of California, Inc. (US)
QIAGEN N.V. (The Netherlands)
RainDance Technologies, Inc. (US)
Roche Sequencing (US)
Shenzhen BGI Diagnosis Co., Ltd. (China)
Thermo Fisher Scientific, Inc. (US)

Key Topics Covered:

1. OVERVIEW

2. COMPETITIVE LANDSCAPE

3. GROWTH DRIVERS, MARKET TRENDS & ISSUES

Expanding Applications of NGS Technology
NGS Revolutionizes Drug Discovery and Development Space
Genetic Information offered by NGS Aids in Drug Development Process
Revolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of Precision Medicine
Rising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS Market
Comparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation Sequencing Methods for Identification of Driver Mutations
NGS Emerges as a Game Changing Technology for Precision Oncology
Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to Patients
Growing Significance of NGS in Enabling Personalized Oncology
Timeline of Major Developments in Sequencing Technologies & Applications Related to Oncology
Personal Genomics Services - Blessing or Bane?
NGS Technology Drives RNA Sequencing in Transcriptomics
Longer Reach of a Read: A Key Feature Considered for Sequencing
qPCR - The Core Technique in NGS Technique
Development of New Systems & Platforms to Fuel NGS Utilization
Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption
Development Efforts Intensify in Long-Read Sequencing
Single-Cell Genomics: A Promising Application of NGS Technology
Shift from Tumor Biopsies to Cancer Liquid Biopsies
NGS Enhances Study of Antimicrobial Resistance
Effective Use of NGS Tools in Public Healthcare Systems
E-Infrastructure for Storage & Analysis of NGS Data
Explosive Growth in Sequencing Data Drives Focus onto Cloud Computing
NGS Hold an Edge Over CE Sequencing Method
Standardization of NGS Technique: A Critical Requirement for Wider Adoption
Challenges Confronting High-throughput Sequencing Market
High Machine Costs and Licensure Fees
Lack of Skilled Personnel
Absence of Regulatory Framework
Limited Access to Scientific Literature and Internet

4. TECHNOLOGY OVERVIEW

5. PRODUCT INNOVATIONS/INTRODUCTIONS

QIAGEN Launches Novel QIAseq NGS Panels
BD Launches BD CLiC System
Immucor and Sirona Genomics Launch MIA FORA NGS
bioMérieux and Illumina Launch bioMérieux EpiSeq NGS Service
Bioline Introduces JetSeq Kit for NGS Sample Preparation
Oxford Gene Technology Launches SureSeq NGS Solutions
GENEWIZ Launches FuzeSeq Antibody Sequencing Technology
Sage Science Launches PippinHT Automated Instruments for Use with NGS
BGI Tech to Launch Two Ranges of NGS - X Bio and Intelligen
Thermo Fisher Scientific Introduces Clinical NGS Oncology Quality Control
Vela Diagnostics Announces Pre-launch of Automated NGS
Rubicon Genomics Launches PicoPLEX DNA-seq Kits for Use with NGS Platforms

6. RECENT INDUSTRY ACTIVITY

Mayo Clinic Collaborates with Illumina on NGS
Sophia Genetics Enters into Partnership with Illumina
Novogene Enters into Collaboration with AITbiotech
Natera Extends Supply Agreement with Illumina
ArcherDX Enters into Collaboration with Illumina
TBUSH to Acquire WaferGen Bio-systems
Advanced Biological Laboratories Signs Distribution Agreement with Thermo Fisher Scientific
Bio-Rad Enters into Partnership with Illumina
SYGNIS AG Signs Distribution Agreement with Lucigen
Almac Diagnostics Enters into Collaboration with Illumina
Roche Acquires Kapa Biosystems
QIAGEN Expands Partnership with BGI
Intel Enters into Partnership with Edico Genome
Illumina Enters into Partnership with Merck Serono
Lockheed Martin and Illumina Enter into Partnership
WuXi PharmaTech Acquires NextCODE Health
Roche Acquires Bina Technologies
CollabRx Enters into Partnership with Cartagenia
New England Biolabs and Directed Genomics Enter into Partnership
Reprogenetics Partners with Illumina
BD Acquires GenCell Biosystems
AB SCIEX and Illumina Enter into OneOmics Partnership Project
Thermo Fisher Scientific, GSK, and Pfizer Enter into Agreement to Develop NGS
AstraZeneca Collaborates with Illumina
Roche Acquires Genia Technologies

7. FOCUS ON SELECT GLOBAL PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 93 (including Divisions/Subsidiaries - 104)

- The United States (61)
- Canada (3)
- Japan (2)
- Europe (27)

- France (1)
- Germany (7)
- The United Kingdom (5)
- Rest of Europe (14)

- Asia-Pacific (Excluding Japan) (11)

For more information about this report visit http://www.researchandmarkets.com/research/kc4hrn/next_generation

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets